Electronic water consumption can reduce oxidative stress in cancer and diabetes patients

13^th International Conference on Metabolomics and Systems Biology

October 11-12, 2018 | Zurich, Switzerland

Masahiro Onuma

Trisguide CO.,LTD, Japan

Scientific Tracks Abstracts: Metabolomics (Los Angel)

Abstract :

Oxidative stress means a state where there is imbalance between the oxidizing action and the reducing action due to reactive oxygen species (ROS) in a living body, resulting in the oxidizing action becoming dominant. Oxidative stress arises as the balance between production and removal is disrupted through excessive production of ROS and impairment of the antioxidant system. Oxidative stress has been reported to be involved in the onset and progress of various diseases. Characteristics of Type 2 diabetes are insulin secretion failure and insulin resistance, but it seems that oxidative stress is greatly involved in insulin secretion failure. In the insulin secretion-inducing β cells of Langerhans islets in the pancreas, the amount of superoxide dismutase (SOD), which is representative of the ROS elimination system, is small and resistance to oxidative stress is considered to be weak. Regarding cancer, it is well known that chronic inflammatory conditions increase the risk of carcinogenesis. Cells such as neutrophils and macrophages are activated in the inflammation area leading to increase in production of active oxygen and nitric oxide. These free radicals cause DNA mutation and cell proliferation thereby promoting cancer development. When chronic inflammation is present, cancer develops more easily. Electronic water, which was developed to generate electron in water, was consumed for three weeks, after meals, between meals and before sleeping 6 times a day, and according to the test subjects' possible time periods. The amount of drinking water was 750-1000 mL, and BAP and d-ROMs checks for all cases were carried out at 4:30 pm. The results of cancer patients and diabetes patients were seen as attached. As a result, the d-ROMs value in the degree of oxidative stress has reduced, and the BAP value, which is an indicator of plasma antioxidant capacity, has improved significantly. Recent Publications 1. Suzuki I et al. (2009) Allopurinol, an inhibitor of uric acid synthesis: can it be used for the treatment of metabolic syndrome and related disorders? Drugs Today. 45(5):363-378. Doi:10.1358/dot.2009.45.5.1370460.

Biography :

Masahiro Onuma pursued his Bachelors in Biochemistry from Tokyo University of Agriculture and Technology. He is the President of TriSGuide Ltd. He has expertise in oxidative disease prevention to use non-medical product based on GSK’s experience of allopurinol which is the strongest anti-oxidant in this world.

E-mail: onuma@trisguide.com